JP MORGAN/CALL/ELI LILLY & CO/700/0.01/17.01.25 | Market Closed - Bid/Ask 11:09:22 27/06/2024 BST | After market 19:48:19 | |||
| 2.24 EUR | +5.16% |
|
2.225 | -0.67% |
| Current month | +35.67% | ||
| 1 month | +41.06% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 27/06/24 | 2.24 | +5.16% |
| 25/06/24 | 2.13 | -0.93% |
| 24/06/24 | 2.15 | +3.37% |
| 21/06/24 | 2.08 | -1.89% |
| 20/06/24 | 2.12 | -1.40% |
Delayed Quote Börse Stuttgart
Last update June 27, 2024 at 11:09 am
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | J.P. Morgan |
| WKN | JK26DT |
| ISIN | DE000JK26DT4 |
| Date issued | 08/02/2024 |
| Strike | 700 $ |
| Maturity | 17/01/2025 (204 Days) |
| Parity | 100 : 1 |
| Emission price | 0.93 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.24 € |
|---|---|
| Lowest since issue | 1.02 € |
| Delta | 0.88x |
| Omega | 3.339 |
| Premium | 3.81x |
| Gearing | 3.79x |
| Moneyness | 1.291 |
| Difference Strike | -205.2 $ |
| Difference Strike % | -29.31% |
| Spread | 0.01 € |
| Spread % | 0.45% |
| Theoretical value | 2.225 |
| Implied Volatility | 35.99 % |
| Total Loss Probability | 17.89 % |
| Intrinsic value | 1.903 |
| Present value | 0.3220 |
| Break even | 938.23 € |
| Theta | -0.01x |
| Vega | 0.01x |
| Rho | 0.03x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
901.3
USD
Average target price
860.5
USD
Spread / Average Target
-4.52%
- Stock Market
- Warrants
- Warrant
